Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a ...
The drug is currently in Phase II stage of clinical trial evaluation to treat IPF. LYT-100: PureTech LYT-100 is PureTech's ...
It is powered by a 1.2-litre three-cylinder petrol engine available in two configurations: the naturally aspirated Puretech 82 engine producing 80 bhp and 115 Nm of torque, and the turbocharged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback